Camtek Ltd. (CAMT) CFO reports sale of 4,404 ordinary shares at up to $172.67

Rhea-AI Filing Summary

Camtek Ltd. Chief Financial Officer Moshe Eisenberg reported open-market sales of Camtek ordinary shares. On 2026-08-12 he sold 645 shares at $172.6717 per share. On 2026-08-11 he sold 3,759 shares at a weighted average price of $160.0561, in multiple trades between $160.00 and $160.5651 per share.

Insider Trade Summary

Net Seller: 4,404 shares

Net Sell 2 txns

Insider Eisenberg Moshe

Role Chief Financial Officer

Sold 4,404 shs ($713K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	645	$172.6717	$111K
Sale	Ordinary Shares F1	3,759	$160.0561	$602K

Holdings After Transaction: Ordinary Shares — 16,239 shares (Direct)

Footnotes (1)

1. F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $160.00 to $160.5651. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request

Key Figures

Total shares sold: 4,404 shares Shares sold 2026-08-12: 645 shares at $172.6717 per share Shares sold 2026-08-11: 3,759 shares at $160.0561 weighted average

3 metrics

Total shares sold 4,404 shares Aggregate of reported sales on 2026-08-11 and 2026-08-12

Shares sold 2026-08-12 645 shares at $172.6717 per share Ordinary Shares, open-market sale

Shares sold 2026-08-11 3,759 shares at $160.0561 weighted average Ordinary Shares, multiple trades between $160.00 and $160.5651

Key Terms

weighted average price, Ordinary Shares, Rule 10b5-1

3 terms

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Ordinary Shares financial

"security_title: Ordinary Shares, transaction_type: non-derivative"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Rule 10b5-1 regulatory

"Rule 10b5-1 checkbox indicates whether trades use a trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did CAMT CFO Moshe Eisenberg report?

Moshe Eisenberg, CFO of Camtek Ltd. (CAMT), reported selling a total of 4,404 ordinary shares of Camtek in open-market transactions on August 11 and 12, 2026, according to the Form 4 filing.

At what prices did the CAMT CFO sell his shares in August 2026?

On August 12, 2026, the CFO sold 645 shares at $172.6717 per share. On August 11, 2026, he sold 3,759 shares at a weighted average price of $160.0561, with individual trades between $160.00 and $160.5651.

How many CAMT shares did the CFO sell on each transaction date?

The Camtek CFO sold 3,759 ordinary shares on August 11, 2026 and 645 ordinary shares on August 12, 2026. In total, the Form 4 reports 4,404 shares sold across these two open-market transactions.

Were the August 11, 2026 CAMT share sales made at a single price?

No. The 3,759 shares sold on August 11, 2026 were executed in multiple trades. The Form 4 reports a weighted average price of $160.0561, with individual trade prices ranging from $160.00 to $160.5651 per share.

Does the CAMT Form 4 indicate trades under a Rule 10b5-1 plan?

The Form 4’s Rule 10b5-1 checkbox is not marked as affirmative, so the reported August 2026 sales by the Camtek CFO are not identified as being made under a Rule 10b5-1 trading plan in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 10:42 AM Accepted by SEC EDGAR 08/13/2026 - 10:41 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eisenberg Moshe

(Last) (First) (Middle)

PO BOX 482

7 HAASIF ST.

(Street)

KFAR HESS

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2026		S		3,759	D	$160.0561(1)	16,884	D
Ordinary Shares	08/12/2026		S		645	D	$172.6717	16,239	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $160.00 to $160.5651. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)